MACROGENICS INC 8-K

What Happened
MacroGenics, Inc. (MGNX) filed an 8-K (Item 5.02) reporting that director Karen Ferrante, M.D., notified the board on July 1, 2026 that she will resign from the company's board of directors effective September 1, 2026. The filing states her decision is for personal reasons and not due to any disagreement with the company’s operations, policies or practices. The report was filed on July 8, 2026 and signed by Jeffrey Peters, Senior VP, General Counsel and Corporate Secretary.

Key Details

• Director Karen Ferrante, M.D. submitted notice of resignation on July 1, 2026.
• Resignation effective date: September 1, 2026.
• Company states resignation is for personal reasons and not the result of any disagreement with company matters.
• 8-K filed July 8, 2026 and signed by Jeffrey Peters.

Why It Matters
A board member departure is a governance change investors should note. This filing provides no indication of operational or policy disputes, and the company thanked Dr. Ferrante for her contributions. Investors tracking MacroGenics’ board composition, governance, or upcoming proxy items may want to watch for any announcement about a replacement director or related corporate governance updates.